The Possible Role of Metformin and Fibroblast Growth Factor‐21 in Multiple Sclerosis Neuropathology: Birds of a Feather Flock Together
European Journal of Neuroscience · 2025-04 · 61 (7)
DOI: 10.1111/ejn.70067 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Neuroscience, online erschienen am 02.04.2025. Verfasst von Ahmad A Abulaban und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Metformin, Fibroblast Growth Factors, Multiple Sclerosis, Neuroprotective Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 223 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Witten-Herdecke Germany.
Abstract (Originalsprache)
Multiple sclerosis (MS) is a progressive demyelinating disease of the CNS, characterized by inflammation, the formation of CNS plaques, and damage to the neuronal myelin sheath (Graphical abstract). Fibroblast growth factor 21 (FGF21) is involved in various metabolic disorders and neurodegenerative diseases. FGF21 and its co‐receptor β‐Kloth are essential in the remyelination process of MS. Metformin, an insulin‐sensitizing drug that is the first‐line treatment for type 2 diabetes mellitus (T2DM), may have a potential neuroprotective impact by up‐regulating the production of FGF21, which may prevent the onset of neurodegenerative diseases including MS. The purpose of this review is to clarify how metformin affects MS neuropathology mechanistically via modifying FGF21. Metformin increases the expression of FGF21. Metformin also increases the expression of β‐Klotho, modulates oxidative stress, reduces glutamate‐induced excitotoxicity, and regulates platelet function and coagulation cascades. In conclusion, metformin can enhance the functional activity of FGF21 in counteracting the development and progression of MS. Preclinical and clinical studies are warranted in this regard.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
- Division of Neurology, King Abdulaziz Medical City, Ministry of the National Guard Health Affairs, Riyadh, Saudi Arabia.
- King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
- Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriya University, Bagdad, Iraq.
- Department of Pharmacology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt.
- Department of Internal Medicine, College of Medicine, Jouf University, Sakaka, Saudi Arabia.
ORCID-Profile: Hayder M Al-Kuraishy, Ali I Al-Gareeb, Eman A Ahmed, Athanasios Alexiou, Gaber El-Saber Batiha
Förderung
- University of Witten-Herdecke Germany
Zitieren
APA
Abulaban, A. A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Ahmed, E. A., Alruwaili, M., Alexiou, A., Papadakis, M., & El-Saber Batiha, G. (2025). The Possible Role of Metformin and Fibroblast Growth Factor‐21 in Multiple Sclerosis Neuropathology: Birds of a Feather Flock Together. European Journal of Neuroscience, 61(7). https://doi.org/10.1111/ejn.70067
Vancouver
Abulaban AA, Al-Kuraishy HM, Al-Gareeb AI, Ahmed EA, Alruwaili M, Alexiou A, et al. The Possible Role of Metformin and Fibroblast Growth Factor‐21 in Multiple Sclerosis Neuropathology: Birds of a Feather Flock Together. European Journal of Neuroscience. 2025;61(7). doi:10.1111/ejn.70067
BibTeX
@article{Abulaban2025,
author = {Abulaban, Ahmad A and Al-Kuraishy, Hayder M and Al-Gareeb, Ali I and Ahmed, Eman A and Alruwaili, Mubarak and Alexiou, Athanasios and Papadakis, Marios and El-Saber Batiha, Gaber},
title = {The Possible Role of Metformin and Fibroblast Growth Factor‐21 in Multiple Sclerosis Neuropathology: Birds of a Feather Flock Together},
journal = {European Journal of Neuroscience},
year = {2025},
volume = {61},
number = {7},
doi = {10.1111/ejn.70067}
}
EUVIMED